WESTBOROUGH, Mass.--(BUSINESS WIRE)--GenomeQuest, Inc., the leader in genomic search, today announced the launch of “DrugBank Pro”, an exclusive database of sequence and annotation information on all approved drugs, their targets and metabolizing enzymes located in the University of Alberta’s DrugBank database, six months prior to publication, along with full access to its non-public Investigational New Drug (IND) database of drugs in clinical trials.
